Cargando…

Prostate Cancer Scoring Index for Risk of Progression of Radioresistant Disease

Prostate cancer (Pca) is among the most common malignant diseases in men and the fourth leading cause of death worldwide. Surgery and radical radiotherapy (RT) remain the gold standard for the treatment of localized or locally advanced prostate cancer. The efficiency of radiotherapy treatment is lim...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tesar, Eleonora Cini, Mikolasevic, Ivana, Skocilic, Iva, Redjovic, Arnela, Vucinic, Damir, Marusic, Jasna, Djordjevic, Gordana
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10222587/ https://www.ncbi.nlm.nih.gov/pubmed/37241040 http://dx.doi.org/10.3390/jpm13050870

Ejemplares similares

Pancreatic Carcinoma Metastatic to the Gingiva
por: Zubović, Arijan, et al.
Publicado: (2021)

Matrix Metalloproteinases 2 and 9 Immunoexpression in Prostate Carcinoma at the Positive Margin of Radical Prostatectomy Specimens
por: Oguić, Romano, et al.
Publicado: (2014)

Spiritual Well-Being for Croatian Cancer Patients: Validation and Applicability of the Croatian Version of the EORTC QLQ-SWB32
por: Dabo, Ivana, et al.
Publicado: (2021)

Drivers of Radioresistance in Prostate Cancer
por: King, Liam, et al.
Publicado: (2022)

Clinical pharmacist-led program on medication reconciliation implementation at hospital admission: experience of a single university hospital in Croatia
por: Marinović, Ivana, et al.
Publicado: (2016)

A gene prognostic index from cellular senescence predicting metastasis and radioresistance for prostate cancer
por: Feng, Dechao, et al.
Publicado: (2022)

Epigenetic mechanisms underlying prostate cancer radioresistance
por: Macedo-Silva, Catarina, et al.
Publicado: (2021)

Targeting radioresistance and replication fork stability in prostate cancer
por: Li, Xiangyi, et al.
Publicado: (2022)

Neuroendocrine Differentiation in Prostate Cancer: A Mechanism of Radioresistance and Treatment Failure
por: Hu, Chang-Deng, et al.
Publicado: (2015)

Fractionated radiation exposure amplifies the radioresistant nature of prostate cancer cells
por: McDermott, N., et al.
Publicado: (2016)

Circ-ABCC4 contributes to prostate cancer progression and radioresistance by mediating miR-1253/SOX4 cascade
por: Yu, Tao, et al.
Publicado: (2022)

Recent progress of the tumor microenvironmental metabolism in cervical cancer radioresistance
por: Zhou, Junying, et al.
Publicado: (2022)

Social support score in patients with malignant diseases—with sociodemographic and medical characteristics
por: Corovic, Snezana, et al.
Publicado: (2023)

LncRNA HULC mediates radioresistance via autophagy in prostate cancer cells
por: Chen, Changxuan, et al.
Publicado: (2018)

Radioresistance in Prostate Cancer: Focus on the Interplay between NF-κB and SOD
por: Kumar, Sameera, et al.
Publicado: (2021)

Kaposi’s sarcoma in an HIV-negative chronic lymphocytic leukemia patient without immunosuppressive therapy: A case report
por: Vučinić, Damir, et al.
Publicado: (2018)

Treatment of Radioresistant Cancers
por: Hendry, J. H.
Publicado: (1980)

Radioresistance of Brain Tumors
por: Kelley, Kevin, et al.
Publicado: (2016)

Exosomes in Cancer Radioresistance
por: Ni, Jie, et al.
Publicado: (2019)

Tumor microenvironment and radioresistance
por: Suwa, Tatsuya, et al.
Publicado: (2021)

Liver and Nonliver-Related Outcomes at 2 Years Are Not Influenced by the Results of the FIB-4 Test and Liver Elastography in a Real-Life Cohort of Patients with Type 2 Diabetes
por: Grgurevic, Ivica, et al.
Publicado: (2021)

Sensitization of Radioresistant Prostate Cancer Cells by Resveratrol Isolated from Arachis hypogaea Stems
por: Chen, Yu-An, et al.
Publicado: (2017)

Differentiation of Normal and Radioresistant Prostate Cancer Xenografts Using Magnetization Transfer-Prepared MRI
por: Lam, Wilfred W., et al.
Publicado: (2018)

PAFR selectively mediates radioresistance and irradiation-induced autophagy suppression in prostate cancer cells
por: Yao, Bing, et al.
Publicado: (2017)

An emerging role of radiation-induced exosomes in hepatocellular carcinoma progression and radioresistance (Review)
por: Fan, Qing, et al.
Publicado: (2022)

Radioresistance in Glioblastoma and the Development of Radiosensitizers
por: Ali, Md Yousuf, et al.
Publicado: (2020)

CircRNAs in Tumor Radioresistance
por: Gao, Yining, et al.
Publicado: (2022)

Mucins Help to Avoid Alloreactivity at the Maternal Fetal Interface
por: Redzovic, Arnela, et al.
Publicado: (2013)

Profiling of a panel of radioresistant prostate cancer cells identifies deregulation of key miRNAs
por: McDermott, Niamh, et al.
Publicado: (2017)

Simvastatin Sensitizes Radioresistant Prostate Cancer Cells by Compromising DNA Double-Strand Break Repair
por: Chen, Yu-An, et al.
Publicado: (2018)

Multiplex profiling identifies clinically relevant signalling proteins in an isogenic prostate cancer model of radioresistance
por: Inder, S., et al.
Publicado: (2019)

Epigenetic regulation of TP53 is involved in prostate cancer radioresistance and DNA damage response signaling
por: Macedo-Silva, Catarina, et al.
Publicado: (2023)

Features of migraine aura in teenagers
por: Petrusic, Igor, et al.
Publicado: (2014)

Vitamin D Deficiency: Consequence or Cause of Obesity?
por: Vranić, Luka, et al.
Publicado: (2019)

Recurrent amelanotic melanoma of nasal cavity: Biological variability and unpredictable behavior of mucosal melanoma. A case report
por: Vučinić, Damir, et al.
Publicado: (2019)

TGF-β1–induced endothelial-mesenchymal transition: a potential contributor to fibrotic remodeling in atrial fibrillation?
por: Saljic, Arnela, et al.
Publicado: (2022)

Endoscopic retrograde cholangiopancreatography-induced and non-endoscopic retrograde cholangiopancreatography-induced acute pancreatitis: Two distinct clinical and immunological entities?
por: Plavsic, Ivana, et al.
Publicado: (2018)

THE ROLE OF LYMPHADENECTOMY IN PROSTATE CANCER PATIENTS
por: Markić, Dean, et al.
Publicado: (2019)

Berberine Inhibited Radioresistant Effects and Enhanced Anti-Tumor Effects in the Irradiated-Human Prostate Cancer Cells
por: Hur, Jung-Mu, et al.
Publicado: (2010)

β-catenin nuclear translocation induced by HIF-1α overexpression leads to the radioresistance of prostate cancer
por: Luo, Yong, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_u8lrmd8p72iaraargof5rcv4co